手術で切除された早期乳がん患者の治療における、1日当たりの高線量放射線療法または1日当たりの標準線量放射線療法

基本情報

NCT ID: NCT01349322
ステータス: 実施中（募集終了）
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: 2,354
治験依頼者名: Radiation Therapy Oncology Group

概要

RATIONALE: It is not yet know whether higher per daily radiation therapy is equally as effective as standard per daily radiation therapy in treating breast cancer. PURPOSE: This randomized phase III trial studies how well an accelerated course of higher per daily radiation therapy with concomitant boost works compared to standard per daily radiation therapy with a sequential boost in treating patients with early-stage breast cancer that was removed by surgery.

対象疾患

Breast Cancer

介入

Standard fractionation whole breast irradiation(RADIATION)

Hypofractionated whole breast irradiation(RADIATION)

Concurrent boost(RADIATION)

Sequential boost(RADIATION)

依頼者（Sponsor）

National Cancer Institute (Nci)(NIH)

Nrg Oncology(OTHER)

Radiation Therapy Oncology Group(NETWORK)

実施施設 (1)

静岡県立静岡がんセンター

Shizuoka, Suntou, Japan